Información:
Error:
ID
34292
Descripción
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function; ODM derived from: https://clinicaltrials.gov/show/NCT02014259
Link
https://clinicaltrials.gov/show/NCT02014259
Palabras clave
Versiones (1)
- 16/1/19 16/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
16 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Diabetes NCT02014259
Eligibility Diabetes NCT02014259
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes NCT02014259
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
male or female aged 18-85 years (both inclusive) at the time of signing inform consent
boolean
ID.2
Item
subject with normal renal function or renal impairment (mild, moderate, severe or end-stage renal disease requiring dialysis)
boolean
ID.3
Item
for subject with normal renal function: good general health (as judged by the investigator)
boolean
ID.4
Item
body mass index (bmi) 18.5-40.0 kg/m^2 (both inclusive)
boolean
ID.5
Item
female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using adequate contraceptive methods
boolean
ID.6
Item
history of crohn's disease, ulcerative colitis, or other inflammatory bowel disease
boolean
ID.7
Item
uncontrolled hypertension (defined as systolic blood pressure above or equal to 180 mmhg and/or diastolic blood pressure above or equal to 100 mmhg)
boolean
ID.8
Item
any blood draw or donation of blood or plasma in excess of 400 ml within the 3 months preceding the screening visit (visit 2)
boolean
ID.9
Item
history of significant drug abuse, or a positive drug test at the screening visit (visit 2)
boolean